Taiwan-based Bora Pharmaceuticals , a global leader in pharmaceutical manufacturing, has announced the appointment of Jean-Baptiste (JB) Agnus as Chief Commercial Officer.
In this role, he will lead Bora’s commercial strategy for its sterile injectables and complex small molecule offerings, as well as playing a key role in its M&A and strategic partnership initiatives.
J.D. Mowery, President of Bora’s CDMO Division said, “JB’s experience and leadership will serve us well as we implement growth and investment strategies to better serve our clients and patients worldwide.”
Agnus joins Bora Group from KBI Biopharma, where he led global business development. Prior to that, he held various senior leadership roles in business development at AGC Biologics, Ajinomoto Bio-Pharma Services, Novasep, and Isochem. He holds a bachelor’s degree in organic chemistry from Université Paul Sabatier Toulouse III, Toulouse, France, and a master’s degree in chemical engineering from Centrale Méditerranée, Marseille, France.
